# Elacytarabine Mass Balance Study in Healthy Volunteers

> **NCT01783964** · PHASE1 · COMPLETED · sponsor: **Clavis Pharma** · enrollment: 6 (actual)

## Conditions studied

- Not Applicable as This is a Mass Balance/Pharmacokinetic Study Performed in Healthy Subjects

## Interventions

- **DRUG:** [14C]-Elacytarabine

## Key facts

- **NCT ID:** NCT01783964
- **Lead sponsor:** Clavis Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-02
- **Final completion:** 2013-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2013-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01783964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01783964, "Elacytarabine Mass Balance Study in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01783964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*